GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2

Angiogenesis

Volumn 16, Issue 4, 2013, Pages 939-952

  Coma, Silvia ^a   Allard Ratick, Marc ^a   Akino, Tomoshige ^a   Van Meeteren, Laurens A ^b,c   Mammoto, Akiko ^a   Klagsbrun, Michael ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; GATA2; Lmo2; Lymphangiogenesis; Neuropilin 2; Transcriptional regulation

Indexed keywords

LIM DOMAIN ONLY 2 PROTEIN; MESSENGER RNA; NEUROPILIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; EMBRYOID BODIES; ENDOTHELIAL CELLS; FEMALE; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIM DOMAIN PROTEINS; LYMPHANGIOGENESIS; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILIN-2; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884815240     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9370-9     Document Type: Article

References (64)

1. Lugus JJ, Park C, Choi K (2005) Developmental relationship between hematopoietic and endothelial cells. Immunol Res 32(1-3):57-74. doi: 10.1385/IR:32:1-3:057
2. Xiong JW (2008) Molecular and developmental biology of the hemangioblast. Dev Dyn 237(5):1218-1231. doi: 10.1002/dvdy.21542
3. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G (1998) A common precursor for hematopoietic and endothelial cells. Development 125(4):725-732
4. Nishikawa SI (2001) A complex linkage in the developmental pathway of endothelial and hematopoietic cells. Curr Opin Cell Biol 13(6):673-678
5. Kubo H, Alitalo K (2003) The bloody fate of endothelial stem cells. Genes Dev 17(3):322-329. doi: 10.1101/gad.1071203
6. Lugus JJ, Chung YS, Mills JC, Kim SI, Grass J, Kyba M, Doherty JM, Bresnick EH, Choi K (2007) GATA2 functions at multiple steps in hemangioblast development and differentiation. Development 134(2):393-405. doi: 10.1242/dev.02731
7. Orkin SH (1992) GATA-binding transcription factors in hematopoietic cells. Blood 80(3):575-581
8. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11(1):40-44. doi: 10.1038/ng0995-40
9. Pevny L, Lin CS, D'Agati V, Simon MC, Orkin SH, Costantini F (1995) Development of hematopoietic cells lacking transcription factor GATA-1. Development 121(1):163-172
10. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH (1994) An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371(6494):221-226. doi: 10.1038/371221a0
11. Molkentin JD, Lin Q, Duncan SA, Olson EN (1997) Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11(8):1061-1072
12. Molkentin JD, Tymitz KM, Richardson JA, Olson EN (2000) Abnormalities of the genitourinary tract in female mice lacking GATA5. Mol Cell Biol 20(14):5256-5260
13. Morrisey EE, Tang Z, Sigrist K, Lu MM, Jiang F, Ip HS, Parmacek MS (1998) GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev 12(22):3579-3590
14. Briegel K, Lim KC, Plank C, Beug H, Engel JD, Zenke M (1993) Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 7(6):1097-1109
15. Kitajima K, Masuhara M, Era T, Enver T, Nakano T (2002) GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO J 21(12):3060-3069. doi: 10.1093/emboj/cdf301
16. Tsai FY, Orkin SH (1997) Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89(10):3636-3643
17. Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ (1997) Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 89(4):1260-1269
18. Kawana M, Lee ME, Quertermous EE, Quertermous T (1995) Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 15(8):4225-4231
19. Lee ME, Temizer DH, Clifford JA, Quertermous T (1991) Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem 266(24):16188-16192
20. Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457(7233):1103-1108. doi: 10.1038/nature07765
21. Kappel A, Schlaeger TM, Flamme I, Orkin SH, Risau W, Breier G (2000) Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood 96(9):3078-3085
22. Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R, Rabbitts TH (1994) The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci USA 91(18):8617-8621
23. Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R (1994) Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J 13(20):4831-4839
24. Visvader JE, Mao X, Fujiwara Y, Hahm K, Orkin SH (1997) The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc Natl Acad Sci USA 94(25):13707-13712
25. Lecuyer E, Herblot S, Saint-Denis M, Martin R, Begley CG, Porcher C, Orkin SH, Hoang T (2002) The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood 100(7):2430-2440. doi: 10.1182/blood-2002-02-0568
26. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 16(11):3145-3157. doi: 10.1093/emboj/16.11.3145
27. Deleuze V, Chalhoub E, El-Hajj R, Dohet C, Le Clech M, Couraud PO, Huber P, Mathieu D (2007) TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol 27(7):2687-2697. doi: 10.1128/MCB.00493-06
28. Deleuze V, El-Hajj R, Chalhoub E, Dohet C, Pinet V, Couttet P, Mathieu D (2012) Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. PLoS ONE 7(7):e40484. doi: 10.1371/journal.pone.0040484
29. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH (1994) The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78(1):45-57
30. Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH (1998) The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 95(7):3890-3895
31. Yamada Y, Pannell R, Forster A, Rabbitts TH (2000) The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci USA 97(1):320-324
32. Yamada Y, Pannell R, Forster A, Rabbitts TH (2002) The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target. Oncogene 21(9):1309-1315. doi: 10.1038/sj.onc.1205285
33. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669-676. doi: 10.1038/nm0603-669
34. Ferrara N, Mass RD, Campa C, Kim R (2007) Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 58:491-504. doi: 10.1146/annurev.med.58.061705.145635
35. Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140(4):460-476. doi: 10.1016/j.cell.2010.01.045
36. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5(1):74-80. doi: 10.1038/ni1013
37. Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J, Hsu AP, Dyack S, Fernandez CV, Chong CE, Babic M, Bardy PG, Shimamura A, Zhang MY, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott HS, Harvey NL (2011) Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 119(5):1283-1291. doi: 10.1182/blood-2011-08-374363
38. Lim KC, Hosoya T, Brandt W, Ku CJ, Hosoya-Ohmura S, Camper SA, Yamamoto M, Engel JD (2012) Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest 122(10):3705-3717. doi: 10.1172/JCI61619
39. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, Murday VA, Hodgson S, Keenan R, Pilz DT, Martinez-Corral I, Makinen T, Mortimer PS, Jeffery S, Trembath RC, Mansour S (2011) Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43(10):929-931. doi: 10.1038/ng.923
40. Ishida H, Imai K, Honma K, Tamura S, Imamura T, Ito M, Nonoyama S (2012) GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia. Eur J Pediatr 171(8):1273-1276. doi: 10.1007/s00431-012-1715-7
41. Klagsbrun M, Eichmann A (2005) A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16(4-5):535-548. doi: 10.1016/j.cytogfr.2005.05.002
42. Ellis LM (2006) The role of neuropilins in cancer. Mol Cancer Ther 5(5):1099-1107. doi: 10.1158/1535-7163.MCT-05-0538
43. Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G (2006) The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett 231(1):1-11. doi: 10.1016/j.canlet.2004.12.047
44. Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, Ellis LM (2009) Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res 15(22):6763-6770. doi: 10.1158/1078-0432.CCR-09-1810
45. Yuan L, Moyon D, Pardanaud L, Breant C, Karkkainen MJ, Alitalo K, Eichmann A (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129(20):4797-4806
46. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126(21):4895-4902
47. Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, Tashiro F, Niwa H, Miyazaki Ji J, Hirota S, Kitamura Y, Kitsukawa T, Fujisawa H, Klagsbrun M, Hori M (2002) Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 99(6):3657-3662. doi: 10.1073/pnas.022017899
48. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92(6):735-745
49. Geretti E, Shimizu A, Klagsbrun M (2008) Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11(1):31-39. doi: 10.1007/s10456-008-9097-1
50. Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cebe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellen L, Klagsbrun M, Claesson-Welsh L (2008) Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 112(9):3638-3649. doi: 10.1182/blood-2007- 12-125856
51. Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, Mandron M, Herault JP, Neufeld G, Savi P, Herbert JM, Bono F (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108(4):1243-1250. doi: 10.1182/blood-2005-11-4447
52. Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, Larrivee B, Del Toro R, Suchting S, Medvinsky A, Silva J, Yang J, Thomas JL, Koch AW, Alitalo K, Eichmann A, Bagri A (2010) Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol 188(1):115-130. doi: 10.1083/jcb.200903137
53. Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, Bischoff J, Klagsbrun M (2008) Calcification of multipotent prostate tumor endothelium. Cancer Cell 14(3):201-211. doi: 10.1016/j.ccr.2008.06.017
54. Li X, Claesson-Welsh L, Shibuya M (2008) VEGF receptor signal transduction. Methods Enzymol 443:261-284. doi: 10.1016/S0076-6879(08)02013-2
55. Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC, Klagsbrun M (2004) Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 114(9):1260-1271. doi: 10.1172/JCI21378
56. Coma S, Shimizu A, Klagsbrun M (2011) Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2. Cell Adh Migr 5(3):266-275
57. Rossignol M, Gagnon ML, Klagsbrun M (2000) Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 70(2):211-222. doi: 10.1006/geno.2000
58. Jakobsson L, Kreuger J, Claesson-Welsh L (2007) Building blood vessels-stem cell models in vascular biology. J Cell Biol 177(5):751-755. doi: 10.1083/jcb.200701146
59. Geretti E, van Meeteren LA, Shimizu A, Dudley AC, Claesson-Welsh L, Klagsbrun M (2010) A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression. Mol Cancer Res 8(8):1063-1073. doi: 10.1158/1541-7786.MCR-10-0157
60. Caunt M, Mak J, Liang WC, Stawicki S, Pan Q, Tong RK, Kowalski J, Ho C, Reslan HB, Ross J, Berry L, Kasman I, Zlot C, Cheng Z, Le Couter J, Filvaroff EH, Plowman G, Peale F, French D, Carano R, Koch AW, Wu Y, Watts RJ, Tessier-Lavigne M, Bagri A (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13(4):331-342. doi: 10.1016/j.ccr.2008.01.029
61. Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, Liu Y, Lee Y, Calvo KR, Keles S, Zhang J, Holland SM, Bresnick EH (2012) Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest 122(10):3692-3704. doi: 10.1172/JCI61623
62. Hong YK, Harvey N, Noh YH, Schacht V, Hirakawa S, Detmar M, Oliver G (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225(3):351-357. doi: 10.1002/dvdy.10163
63. Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ, Tsai SY (2010) Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 120(5):1694-1707. doi: 10.1172/JCI40101
64. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY (2005) Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435(7038):98-104. doi: 10.1038/nature03511